CN100339097C - Compound ointment for treating acne - Google Patents
Compound ointment for treating acne Download PDFInfo
- Publication number
- CN100339097C CN100339097C CNB2005100168751A CN200510016875A CN100339097C CN 100339097 C CN100339097 C CN 100339097C CN B2005100168751 A CNB2005100168751 A CN B2005100168751A CN 200510016875 A CN200510016875 A CN 200510016875A CN 100339097 C CN100339097 C CN 100339097C
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- ointment
- present
- salicylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides compound ointment for treating acne, which is composed of honeysuckle flowers, forsythia fruits, scutellaria roots, phellodendron bark, peppermint, metronidazole, phenol, salicylic acid and cream stroma. According to a traditional ointment preparation process in pharmacy, the honeysuckle flowers, the forsythia fruits, the scutellaria roots, the phellodendron bark, the peppermint and the metronidazole are pulverized into powder of 100 to 120 meshes; the phenol, the salicylic acid and the cream stroma are added and stirred in uniformity, and the compound ointment for treating acne is obtained. The present invention has the functions that diseases, such as acne, acne infection and scars, are transferred from deep parts to superficial parts of skin and from the superficial parts to outside of a human body, and finally stasis toxin disappears. The diseases can no relapse after cure, the immune function of the human body is improved greatly, and no scar is left after cure. Particularly, under the condition of ineffective treatment to local skin infection by various antibiotics, the therapeutic effect of the present invention is still obvious, and the cure rate is very high.
Description
Technical field:
The present invention relates to acne, acne infection and cicatrix disease treatment of diseases medicine, a kind of acne compound recipe ointment is provided, belong to Chinese medicine Drug therapy skin infection technical field.
Background technology:
Acne young crowd, occurs in face as a kind of commonly encountered diseases pilosity, also can occur in thoracic dorsal top and shoulder, also betides the red pimple at other positions once in a while.The vigorous position of sebaceous gland is heavy, the position that smegma is few light (all skin of socket of the eye never involves).The patient is an oily skin mostly, and beginning mostly is homeliness type greatly, tuberosity, pustule, abscess, sinus tract or cicatrix can occur later on.The course of disease is long, and easily repeatedly, many no conscious symptons, then can cause pain and touch painful when obvious as inflammation.
The external curing medicine is oxygen benzoyl or tetracycline ointment, erythromycin ointment or lincomycin ointment on the market, antibiotic such as Azelex, some hormonal medicaments of also interpolation that have; its therapeutic effect has certain limitation; subject range is less, can not remove this sick pathogenesis, also is difficult to this palindromia of control; cure the symptoms, not the disease; outbreak repeatedly is difficult to cure, after long-time the use; medicine produces also human body can untoward reaction, and the malpractice that damages the appearance face has generation frequently.
Summary of the invention:
Disclosed by the invention is a kind of acne compound recipe ointment, and the Chinese and western drugs combination does not contain hormone, and is evident in efficacy, treating both the principal and secondary aspects of a disease.
The present invention is according to medically to the pathogenesis and the Therapeutic Principle of acne, selected pure Chinese herbal medicine with functions such as heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, anti-inflammatory anti-itchs, in conjunction with modern Western medicine drug, make compound medicinal formulation through the science process of preparing Chinese medicine and rigorous operation, be used to eliminate the sick mechanism of acne, make body recovery normal.
Basic prescription of the present invention is by the following medicine Chinese medicine preparation made of component by ratio of weight and the number of copies:
Flos Lonicerae 10~15, Fructus Forsythiae 10~15, Radix Scutellariae 10~15, Cortex Phellodendri 5~10, Herba Menthae 3~5, metronidazole 20~50, phenol 1~4, salicylic acid 30~70, emulsifiable paste matrix 500~1000.
Preferred prescription of the present invention is:
15 parts of Flos Loniceraes, 10 parts of Fructus Forsythiaes, 15 parts of Radix Scutellariaes, 8 parts of Cortex Phellodendris, 3 parts of Herba Menthaes, 30 parts of metronidazoles, 2 parts of phenol, 50 parts of salicylic acid, 800 parts of emulsifiable paste matrixes.
Concrete processing procedure of the present invention is as follows:
According to ointment processing technology traditional on the pharmaceutics, Flos Lonicerae, Fructus Forsythiae, Radix Scutellariae, Cortex Phellodendri, Herba Menthae, metronidazole are pulverized 100~120 orders, adding phenol, salicylic acid, emulsifiable paste matrix stir, and make the mallorca acne Mallorca ointment; Concrete technology should meet 2000 editions unguentum projects of Pharmacopoeia of People's Republic of China relevant requirements.
Flos Lonicerae, Fructus Forsythiae have heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain effect among the present invention, Radix Scutellariae, Cortex Phellodendri, Herba Menthae reducing heat and dispersing lung-QI; Salicylic acid, phenol pain relieving, itch stopping and diminish inflammation suppress smegma, and it is open to increase the sebum glandular orifice; Metronidazole is used to kill anaerobe, and the growth of antibacterial is disturbed in synthesizing of the DNA (deoxyribonucleic acid) of inhibition antibacterial; The Chinese and western drugs compatibility is scientific and reasonable, brings out the best in each other, and gos deep into focus, to reach therapeutic purposes.
Indication of the present invention comprises: acne, acne infection and cicatrix disease disease.
Instructions of taking: the coating of usual amounts affected part, every day 2~3 times.
The present invention can will mention superficial part by the skin deep part of acne, acne infection and cicatrix disease, and superficial part is mentioned external, and last stasis of blood poison disappears, and no longer recurrence has improved immune function of human body greatly after healing, more the back preventing from scar.Particularly various antibiotic therapy local skins are infected under the invalid situation, therapeutic effect of the present invention is still remarkable, and cure rate is high.
Further specify curative effect of the present invention with regard to clinical effectiveness of the present invention below:
Criterion:
Clinical recovery---symptom complete obiteration, main physico-chemical examination index is normal.
Effectively---cardinal symptom disappears, and the pathological changes area diminishes, and main physical and chemical index makes moderate progress.
Invalid---with the treatment before compare, each side does not all have improvement.
Clinical statistics application T statistical theory is treated recovery from illness 89 examples (89%), effective 8 examples (8%), invalid 3 examples (3%) to the patient of the local skin infection of 100 routine different parts skins.
Case 1
Jiang, the man, 39 years old, facial acne for many years, in the recent period concurrent infection is existing 6 months, diagnosis: the acne concurrent infection, use multiple external tretinoin medicines to fail to respond to any medical treatment; Coated medicine of the present invention is after one week, and sx used one month continuously, and facial area acne and infection all disappear, and follows up a case by regular visits to and does not have bounce-back in 6 months.
Case 2
Surplus certain, woman, 28 years old, the civil servant suffered from acne with rear face in 20 years old, and is serious gradually, so that the red pimple of large tracts of land appears in thoracic dorsal top and shoulder, seeking the treatment treatment does not have significant curative effect for many years, and body is looked into and is hyperactivity of toxic heat type acne, and coated medicine of the present invention is after one week, the red pimple sx of facial area acne and health, used one month continuously, facial area acne and infection all disappear, and follow up a case by regular visits to and do not have bounce-back in 6 months.
Case 3
Lee, the man, 20 years old, adolescence,, the whole face acne was serious, and part infects, and coated medicine of the present invention is after one week, and sx makes two months continuously, and facial area acne and infection all disappear, and follow up a case by regular visits to and do not have bounce-back in 6 months.
Good effect of the present invention is: with pure Chinese herbal medicine is raw material, through the science preparation, very strong anti-inflammatory analgetic ability is arranged, and no skin allergy phenomenon takes place, and treatment cycle is short, do not rebound after the healing, and wide accommodation, curative effect is reliable, has no side effect.Advantage of the present invention is that expense is low, short treating period, good effect, no pain, and medication is convenient, and is applied widely, without any side effects.
The specific embodiment:
To further specify the present invention in following examples, but not limit the present invention in any way.
Embodiment 1
According to ointment processing technology traditional on the pharmaceutics, Flos Lonicerae 10kg, Fructus Forsythiae 15kg, Radix Scutellariae 10kg, Cortex Phellodendri 8kg, Herba Menthae 3kg, metronidazole 20kg are pulverized 100~120 order fine powders, adding phenol 3kg, salicylic acid 35kg, emulsifiable paste matrix 800kg stir, and make the mallorca acne Mallorca ointment; Concrete technology should meet 2000 editions unguentum projects of Pharmacopoeia of People's Republic of China relevant requirements.
Embodiment 2
Flos Lonicerae 15kg, Fructus Forsythiae 15kg, Radix Scutellariae 10kg, Cortex Phellodendri 5kg, Herba Menthae 5kg, metronidazole 45kg are pulverized 100~120 order fine powders, adding phenol 3kg, salicylic acid 35kg, emulsifiable paste matrix 100kg stir, according to ointment processing technology traditional on the pharmaceutics, make the mallorca acne Mallorca ointment; Concrete technology should meet 2000 editions unguentum projects of Pharmacopoeia of People's Republic of China relevant requirements.
Embodiment 3
According to traditional ointment processing technology, Flos Lonicerae 15kg, Fructus Forsythiae 10kg, Radix Scutellariae 10kg, Cortex Phellodendri 10kg, Herba Menthae 3kg, metronidazole 30kg are pulverized 100~120 order fine powders, adding phenol 4kg, salicylic acid 65kg, emulsifiable paste matrix 800kg stir, and make the mallorca acne Mallorca ointment; Concrete technology should meet 2000 editions unguentum projects of Pharmacopoeia of People's Republic of China relevant requirements.
Embodiment 4
Flos Lonicerae 15kg, Fructus Forsythiae 10kg, Radix Scutellariae 15kg, Cortex Phellodendri 8kg, Herba Menthae 3kg, metronidazole 30kg are pulverized 100~120 order fine powders, and adding phenol 4kg, salicylic acid 65kg, emulsifiable paste matrix 800kg stir, and make the mallorca acne Mallorca ointment; Concrete technology should meet 2000 editions unguentum projects of Pharmacopoeia of People's Republic of China relevant requirements.
Claims (1)
1, a kind of compound ointment for treating acne is characterized in that being made by following materials of weight proportions medicine:
10~15 parts of Flos Loniceraes, 10~15 parts of Fructus Forsythiaes, 10~15 parts of Radix Scutellariaes, 5~10 parts of Cortex Phellodendris, 3~5 parts of Herba Menthaes, 20~50 parts of metronidazoles, 1~4 part of phenol, 30~70 parts of salicylic acid, 500~1000 parts of emulsifiable paste matrixes, Flos Lonicerae, Fructus Forsythiae, Radix Scutellariae, Cortex Phellodendri, Herba Menthae, metronidazole are pulverized 100~120 orders, adding phenol, salicylic acid, emulsifiable paste matrix stir, and make the mallorca acne Mallorca ointment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100168751A CN100339097C (en) | 2005-06-15 | 2005-06-15 | Compound ointment for treating acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100168751A CN100339097C (en) | 2005-06-15 | 2005-06-15 | Compound ointment for treating acne |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1709322A CN1709322A (en) | 2005-12-21 |
CN100339097C true CN100339097C (en) | 2007-09-26 |
Family
ID=35705654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100168751A Expired - Fee Related CN100339097C (en) | 2005-06-15 | 2005-06-15 | Compound ointment for treating acne |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100339097C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103735821B (en) * | 2014-01-29 | 2015-11-18 | 宋英明 | A kind of composite medical ointment for the treatment of acne |
CN106860684A (en) * | 2015-12-10 | 2017-06-20 | 丁惠端 | A kind of traditional Chinese medicine fumigating bubble for treating small pox and preparation method thereof |
CN110934956A (en) * | 2020-01-01 | 2020-03-31 | 吕银山 | Acne removing cream |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1123170A (en) * | 1994-11-18 | 1996-05-29 | 吕建京 | Children's oral-medicine for clearing away heat and toxic material and preparation technology thereof |
CN1130083A (en) * | 1995-10-13 | 1996-09-04 | 武丽莉 | Oral administration liquid for curing acne and its preparing method |
CN1151879A (en) * | 1995-12-14 | 1997-06-18 | 祝继兴 | Chinese medicine granule for acne |
-
2005
- 2005-06-15 CN CNB2005100168751A patent/CN100339097C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1123170A (en) * | 1994-11-18 | 1996-05-29 | 吕建京 | Children's oral-medicine for clearing away heat and toxic material and preparation technology thereof |
CN1130083A (en) * | 1995-10-13 | 1996-09-04 | 武丽莉 | Oral administration liquid for curing acne and its preparing method |
CN1151879A (en) * | 1995-12-14 | 1997-06-18 | 祝继兴 | Chinese medicine granule for acne |
Also Published As
Publication number | Publication date |
---|---|
CN1709322A (en) | 2005-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102688383A (en) | Traditional Chinese medicine composite for treating body surface ulcer or fester | |
CN100339097C (en) | Compound ointment for treating acne | |
CN103656092A (en) | Ointment for treating trauma and preparation method thereof | |
CN1053824C (en) | Exterior-use traditional Chinese medicine ointment and its preparing method | |
CN1183950C (en) | Chinese herbal medicine preparation for treating burns | |
CN1325096C (en) | Chinese medicine formulation for treating ance disease | |
CN1261140C (en) | Medicine for treating burns and scalds | |
CN1128633C (en) | Exterior-applied medicine for treating gynopathy | |
CN103735821B (en) | A kind of composite medical ointment for the treatment of acne | |
CN1895593A (en) | Medicine for treating acne and its preparation | |
CN1180833C (en) | Chinese medicine against skin and external diseases | |
CN105233258A (en) | Composition for removing acne | |
CN1063820A (en) | The manufacture method of tinea unguium dissolving cream | |
CN102018874A (en) | Traditional Chinese medicine preparation for treating swelling | |
CN101530516A (en) | Chinese medicament for treating appendicitis | |
CN1186068C (en) | Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process | |
CN1257732C (en) | Medicine for treating mastosis and preparation process thereof | |
CN1136857C (en) | Traditional Chinese medicine external preparation for curing piles | |
CN1244351C (en) | Compound powder peparation for curing gynecopathy, its preparation method and application | |
CN1181837C (en) | Medicine for curing burn and scald | |
CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
CN1175844C (en) | Externally-applied medicine for treaitng red swelling | |
CN1453002A (en) | Inflammation diminishing and granulation promoting ointment | |
CN101019998A (en) | Medicine for treating anorectal diseases | |
CN1084748A (en) | Quick results arthritis dressing and manufacture method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |